全文获取类型
收费全文 | 3155篇 |
免费 | 93篇 |
国内免费 | 116篇 |
学科分类
医药卫生 | 3364篇 |
出版年
2023年 | 16篇 |
2022年 | 23篇 |
2021年 | 56篇 |
2020年 | 57篇 |
2019年 | 91篇 |
2018年 | 102篇 |
2017年 | 52篇 |
2016年 | 51篇 |
2015年 | 33篇 |
2014年 | 189篇 |
2013年 | 260篇 |
2012年 | 127篇 |
2011年 | 178篇 |
2010年 | 109篇 |
2009年 | 115篇 |
2008年 | 137篇 |
2007年 | 129篇 |
2006年 | 113篇 |
2005年 | 117篇 |
2004年 | 118篇 |
2003年 | 109篇 |
2002年 | 82篇 |
2001年 | 51篇 |
2000年 | 66篇 |
1999年 | 57篇 |
1998年 | 59篇 |
1997年 | 59篇 |
1996年 | 48篇 |
1995年 | 43篇 |
1994年 | 56篇 |
1993年 | 61篇 |
1992年 | 50篇 |
1991年 | 60篇 |
1990年 | 61篇 |
1989年 | 44篇 |
1988年 | 46篇 |
1987年 | 47篇 |
1986年 | 34篇 |
1985年 | 41篇 |
1984年 | 36篇 |
1983年 | 33篇 |
1982年 | 34篇 |
1981年 | 25篇 |
1980年 | 17篇 |
1979年 | 19篇 |
1978年 | 18篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有3364条查询结果,搜索用时 15 毫秒
11.
12.
D. E. Uehlinger P. Weidmann M. P. Gnaedinger 《European journal of clinical pharmacology》1989,36(2):119-125
Summary Co-dergocrine has recently been demonstrated acutely to lower plasma norepinephrine (NE) and blood pressure (BP) in patients
with essential hypertension, and similar results have been obtained during chronic administration of co-dergocrine to healthy
men. The present study investigated the effect of 3 weeks of treatment with co-dergocrine 4 mg/day on BP, plasma catecholamines,
certain other BP-regulating factors and serum lipoproteins in patients with essential hypertension.
Compared to placebo conditions, co-dergocrine decreased supine BP and heart rate by −7% and the upright plasma NE level by
−24%. Supine plasma NE also fell (−24%). Total cholesterol and the LDL + VLDL-cholesterol lipoprotein fraction were lowered
by −6%.
No significant change was observed in plasma renin activity, angiotensin II, aldosterone and epinephrine levels, whole blood
and plasma volume, exchangeable sodium, and the cardiovascular responsiveness to NE, angiotensin II and isoproterenol.
The findings suggest that in patients with essential hypertension, chronic treatment with co-dergocrine may slightly decrease
sympathetic outflow and, at least in the short-term, lower the potentially atherogenic serum LDL + VLDL − cholesterol fraction. 相似文献
13.
Immunochemical techniques have been used to identify five antigenic (Ag) sites on apolipoprotein B-100 (apoB), the major protein constituent of very low density (VLDL), intermediate density (IDL), and low density lipoproteins (LDL). Each Ag site results from allelic variation at a specific locus of the apoB gene. In the present study, we assessed whether variations in the five Ag loci were associated with concentrations of plasma lipids or lipoprotein fractions measured by analytical ultracentrifugation in a group of 44 healthy men. Pair-wise analyses of the Ag markers revealed that Ag(a1/d), in association with either Ag(x/y) or Ag(t/z), is significantly related to plasma IDL-mass concentrations. In this cohort we detected no significant associations of the Ag alleles (singly or in combination) with plasma total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol, or mass of total VLDL or LDL. These results suggest that genetic variations in the apoB molecule may predispose to variations in concentrations of IDL that could have consequences for atherosclerotic risk. 相似文献
14.
冠心病病人氧化修饰低密度脂蛋白的测定及临床意义 总被引:1,自引:0,他引:1
目的 :探讨氧化修饰低密度脂蛋白 (Ox LDL)对冠心病 (CHD)形成和发展的影响。方法 :CHD组 6 0例 ,对照组 5 3例。用酶标多克隆抗体夹心的方法检测血清Ox LDL含量。结果 :CHD组血清Ox LDL含量为 ( 48.6± 32 .8) μg dl。对照组( 2 5 .9± 2 2 .5 ) μg dl,两组之间Ox LDL含量存在显著性差异 (P <0 .0 0 1)。 结论 :Ox LDL和CHD有密切的关系 ,故可作为CHD病人特异性的辅助诊断指标。 相似文献
15.
本实验探讨安妥明对实验性高胆固醇血症大鼠脂质代谢紊乱的影响。实验结果表明安妥明除具有已知的降低血清T—C、LDL—C和VLDL—C作用外,还可明显升高高胆固醇血症大鼠的血清HDL—C水平和LCAT活性,同时能明显降低血清及肝脏IPO的形成。进一步观察表明,安妥明对高密度脂蛋白亚组份的作用是使HDL_2-C升高,而对HDL_3-C无明显影响。 相似文献
16.
R. P. F. DULLAART W. J. SLUITER L. D. DIKKESCHEI† K. HOOGENBERG A. VAN TOL‡ 《European journal of clinical investigation》1994,24(3):188-194
Abstract. The mechanisms responsible for the decreased high density lipoprotein (HDL) cholesterol levels associated with obesity and insulin resistance are not well understood. Lecithin: cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP) are key factors in the esterification of cholesterol in HDL and the subsequent transfer of cholesteryl ester towards apolipoprotein B-containing lipoproteins. Phospholipid transfer protein (PLTP) may be involved in the regulation of HDL particle size. We therefore measured the activities of LCAT, CETP and PLTP using exogenous substrate assays, as well as lipids, lipoproteins, insulin and C-peptide in fasting plasma from eight healthy obese men (body mass index >27 kg m-2) and 24 non-obese subjects. The obese men had lower levels of HDL cholesterol (P<0·05) and higher levels of plasma triglycerides (P<0·05), insulin (P<0·05) and C-peptide (P<0·01), as compared to the quartile of subjects with the lowest body mass index (BMI <22·4 kg m-2). CETP and PLTP activities were elevated in the obese men by 35% (P<0·01) and by 15% (P<0·05), respectively. LCAT activity was comparable among the quartiles. Linear regression analysis showed that CETP activity was positively correlated with body mass index (P<0·02), fasting blood glucose (P7lt;0·05) and plasma C-peptide (P<0·05). PLTP activity was positively related to body mass index (P<0·01), waist to hip circumference ratio (P<0·001), as well as to fasting blood glucose (P<0·05) and plasma C-peptide (P<0·05) It is concluded that the activities of CETP and PLTP are influenced by adiposity and possibly by insulin resistance. Elevated lipid transfer protein activities may provide a mechanism that contributes to alterations in HDL in insulin resistant states. 相似文献
17.
老年冠心病病人血清甲状腺激素与血脂水平的检测 总被引:3,自引:0,他引:3
①目的 探讨老年冠心病病人血清中甲状腺激素水平及与血脂的关系。②方法 测定 30例正常对照者及 4 7例冠心病病人血清中总胆固醇 (TC)、三酰甘油 (TG)、高密度脂蛋白 (HDL)、低密度脂蛋白 (LDL)、载脂蛋白A1、载脂蛋白B、游离三碘甲状腺原氨酸 (FT3 )、游离甲状腺素 (FT4)、促甲状腺素 (TSH)水平。③结果 冠心病组FT3 、HDL、载脂蛋白A1明显低于正常对照组 (t=4 .12 4~ 5 .910 ,P <0 .0 1) ;FT4、TSH、TG、TC两组间比较无显著性差异 (t=1.4 33~ 1.85 4 ,P >0 .0 5 ) ;LDL与载脂蛋白B明显高于正常对照组 (t=3.70 5、7.6 5 0 ,P <0 .0 1)。冠心病病人FT3 、FT4与TC、TG无相关性 (r=- 0 .0 5 9~ - 0 .0 0 3,P >0 .0 5 ) ,与HDL、载脂蛋白A1呈正相关 (r =0 .32 8~ 0 .72 0 ,P<0 .0 1) ,与LDL、载脂蛋白B呈负相关 (r=- 0 .80 2~ - 0 .4 0 7,P <0 .0 5 )。④结论 冠心病病人存在FT3 下降 ,甲状腺激素水平下降可影响脂蛋白的正常代谢。 相似文献
18.
19.
The relationship between high-density-lipoprotein (HDL) particle size subclasses and the levels of the major lipoprotein lipids was studied in 74 men consecutively referred to the lipid clinic. HDL (density 1.070-1.21 kg l-1) was separated by polyacrylamide gradient gel electrophoresis (GGE) into five size-defined subclasses, in order of decreasing size as follows: HDL2b, HDL2a, HDL3a, HDL3b and HDL3c. Cholesterol and triglyceride concentrations in very-low-density (VLDL), low-density (LDL) and high-density (HDL) lipoproteins were determined. The level of VLDL triglycerides was negatively correlated with HDL2b (r = -0.66, P less than 0.0001), and positively correlated with HDL3b concentrations (r = 0.65, P less than 0.0001). Both correlations were restricted to subjects with VLDL triglyceride concentrations of less than 1.80 mmol l-1, i.e. those with normotriglyceridaemia. Patients with a history of myocardial infarction and/or angina pectoris (n = 18) had significantly lower HDL2b levels than subjects with asymptomatic hyperlipidaemia (n = 50), i.e. 0.16 vs. 0.22 mg protein ml-1 (P less than 0.05), despite essentially similar cholesterol and triglyceride levels in the VLDL, LDL and HDL fractions, including HDL2 and HDL3 cholesterol. 相似文献
20.
脑梗死患者血浆氧化低密度脂蛋白与一氧化氮、假性血友病因子及血浆颗粒膜蛋白的关系研究 总被引:3,自引:0,他引:3
目的探讨动脉粥样硬化性脑梗死患者血浆氧化低密度脂蛋白与血管内皮损伤及血小板活化程度的关系。方法用酶联免疫吸附测定(ELISA)的方法检测49例脑梗死患者和50例相匹配的对照组血浆氧化低密度脂蛋白(OX-LDL)、血管性假血友病因子(VWF)、血浆颗粒膜蛋白(GMP-140)水平,同时用硝酸还原酶比色法测定血清一氧化氮(NO)水平,并把、VWF、GMP-140、NO与OX-LDL作相关分析。结果脑梗死组血浆OX-LDL、、VWF、GMP-140明显高于对照组(t=2.91,P〈0.01;t=3.94,P〈0.001;t=2.08,P〈0.05),而脑梗死组血清NO水平明显低于对照组(t=4.02,P〈0.001);相关分析表明血浆OX-LDL水平与血清NO水平呈负相关(r=-0.204,P〈0.05),与血浆懈呈正相关(r=0.60,P〈0.01),与血浆GMP-140呈正相关(r=0.430,P〈0.01)。结论脑梗死患者的血浆OX-LDL明显增高,而OX-LDL增高可能是脑梗死的危险因素。 相似文献